Heart and Vascula...
Follow
Find tag "theheart.org"
24.1K views | +5 today
Heart and Vascular Health
Media, News & Topics on prevention, diagnosis & treatment of cardiovascular disease
Your new post is loading...
Scooped by Seth Bilazarian, MD
Scoop.it!

New Cholesterol guidelines from ACC/AHA.

New Cholesterol guidelines from ACC/AHA. | Heart and Vascular Health | Scoop.it

This downloadable spreadsheet is a companion tool to the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. The spreadsheet enables health care providers and patients to estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD), defined as coronary death or nonfatal myocardial infarction, or fatal or nonfatal stroke, based on the Pooled Cohort Equations and the work of Lloyd-Jones, et al., respectively. The information required to estimate ASCVD risk includes age, sex, race, total cholesterol, HDL cholesterol, systolic blood pressure, blood pressure lowering medication use, diabetes status, and smoking status,  Its here =>

http://goo.gl/d9NldB

Seth Bilazarian, MD's insight:

Many changes for management of patients with statin medications, based on 2013 ACC/AHA guidelines.  My Vlog review of these changes for community based physicians and patients at theheart.org and Medscape reviews the changes. 

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

Pradaxa turns 19 (in dog years)

Pradaxa turns 19 (in dog years) | Heart and Vascular Health | Scoop.it

As Pradaxa (dabigatran) celebrates its second anniversary since FDA approval, the clock is ticking to 2018, when its first patent is set to expire.  What are the impediments to new blood thinners despite a strong set of data from the development of this first in class new blood thinner. My thoughts in theheart.org Vlog.

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

Transcatheter Aortic Valve Replacement: What's in a Name?

Transcatheter Aortic Valve Replacement: What's in a Name? | Heart and Vascular Health | Scoop.it

Keeping up with doctor speak can be a full time job (even for doctors).  I blogged about this previously entitled: STEMI, ADHF, MVO, VTE, CSL: The moving target of acronyms in cardiology

http://blogs.theheart.org/private-practice/2010/9/9/stemi-adhf-mvo-vte-csl-the-moving-target-of-acronyms-in-cardiology

The treatment of severely narrowed aortic valves with a catheter rather than surgery had been called Transcather Aortic Vave Implantation (TAVI) since the old valve is not repalced - the new valve is placed or implanted inside the old one.  The cardiology journal JACC decided to rename this TAVR for replacement instead of implant even though there is no replacement.  If you missed this arbitrary switch it's OK since they have decided to switch back.  Sometimes being behind the news curve is more efficient. For now,  we can say TAVR was the old term before we switched back to the older term TAVI.  What's old is new again.

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

The Choosing Wisely initiative: The ACC and ASNC list what NOT to do

The Choosing Wisely initiative: The ACC and ASNC list what NOT to do | Heart and Vascular Health | Scoop.it

My Vlog:

Based on the notion that up to 30% of healthcare spending may be wasteful, the Choosing Wisely initiative lists what procedures to avoid. Are you aware of the American College of Cardiology and the American Society of Nuclear Cardiology lists?

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

What to do about bridging with novel oral anticoagulants

What to do about bridging with novel oral anticoagulants | Heart and Vascular Health | Scoop.it
Sharing a rare moment of person-to-person time during the scientific sessions in San Francisco, Dr Seth Bilazarian asks Drs Samuel Goldhaber how he goes about bridging with dabigatran, rivaroxaban, and apixaban.
Seth Bilazarian, MD's insight:

All of the new blood thinners or novel oral anticoagulants (NOAC)  have a warning in their label about the hazard of stopping them. These agents have a short half life so within 1 - 2 days they are out of the system and there is no blood thinner protection from the hazard of atrial fibrillation (AF).  Should patients going for procedures receive "bridging" with intravenous (IV) blood thinners to protect them during the interval off these new agents.  Perspective from Sam Goldhaber of the Clot Blog on theheart.org.

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

Seth Bilazarian Vlog: What to do about hospital readmission rates

Seth Bilazarian Vlog: What to do about hospital readmission rates | Heart and Vascular Health | Scoop.it

As the CMS moves to cut reimbursement based on high rates of hospital readmission for MI, heart failure, and pneumonia, how can cardiologists—working with other healthcare providers, patients, and their families—provide optimum care and keep people out of the hospital?

Is preventing readmission the base way to judge quality? Can hospitals control social and home life issues that have a huge impact on admission and readmission

more...
No comment yet.
Scooped by Seth Bilazarian, MD
Scoop.it!

Social Media for Cardiologists

Social Media for Cardiologists | Heart and Vascular Health | Scoop.it
Should cardiologists be interested in social media? Do they follow their colleagues on Twitter? Is it better for physicians not to join Facebook?

Drs Seth Bilazarian & Westby Fisher sit down with heartwire's Shelley Wood to talk about how they got their start in social media and why they think their colleagues should join this worldwide conversation.

> Two experts (Shelly and Wes) & a Social Media Novice (me) encourage cardiologists to engage these new information platforms.

more...
No comment yet.